Peking University People's Hospital
Clinical trials sponsored by Peking University People's Hospital, explained in plain language.
-
New combo therapy shows promise for rectal cancer patients
Disease control CompletedThis study tested a treatment plan for people with advanced rectal cancer that had not spread. Patients received chemotherapy with radiation, followed by three doses of an immunotherapy drug called Sintilimab. The goal was to see if this combination could make the cancer disappea…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 26, 2026 05:09 UTC
-
Remote sleep apnea care matches In-Person for blood pressure control
Disease control CompletedThis study tested whether managing obstructive sleep apnea (OSA) through telemedicine can lower blood pressure as effectively as traditional in-person clinic visits. 344 adults with suspected OSA in Beijing used a breathing machine (APAP) at home, with either remote monitoring or…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New combo boosts platelet counts in stubborn blood disorder
Disease control CompletedThis study tested whether adding ATRA to eltrombopag works better than eltrombopag alone for adults with immune thrombocytopenia (ITP) that did not respond to steroids. ITP causes low platelet counts, leading to bleeding risks. The trial enrolled 96 participants and measured how …
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
Weight loss before IVF boosts baby chances for overweight women
Disease control CompletedThis study looked at whether losing weight before in vitro fertilization (IVF) helps overweight and obese women have a live birth. Researchers followed 197 women aged 20-36 who were having their first IVF treatment. Some women followed a diet and exercise program for 3 months bef…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New pill shows promise for arthritis sufferers in early trial
Disease control CompletedThis study tested a new daily medication called Proximod for people with moderate-to-severe rheumatoid arthritis who did not get enough relief from standard treatments. 179 participants took either a low or high dose of Proximod or a placebo for three months. The goal was to see …
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New drug shows promise for stubborn thyroid eye disease
Disease control CompletedThis study tested a new medicine called IBI311 for people with thyroid eye disease that did not get better with steroids. The medicine is an antibody that blocks a protein linked to eye bulging and inflammation. The study involved 53 adults and measured if the treatment could red…
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Energy drinks or warming mats? study finds best way to keep moms warm during C-Sections
Symptom relief CompletedThis study looked at two ways to prevent women from getting cold during planned C-sections: drinking an energy drink before surgery or using a warming mattress. 302 women having planned C-sections took part. The goal was to see if the energy drink worked as well as the warming ma…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated May 26, 2026 05:05 UTC
-
New study reveals hidden antibody dangers after stem cell transplants
Knowledge-focused CompletedThis study looked at 314 people who received stem cell transplants from donors that were not a perfect match. The goal was to track how often patients develop donor-specific antibodies after transplant, which can lead to graft rejection or failure. Researchers hope this knowledge…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC